ONAA for mild to moderate Alzheimer's dementia

The I9M-MC-ONAA clinical research study will test how certain proteins in the spinal fluid of people with Alzheimers disease change after treatment with an investigational drug.

People who meet the following criteria may be eligible to participate:

• 50-89 years old
• have mild to moderate Alzheimers Dementia
• willing to have 2 Lumbar Punctures

All participants receive the real drug (there is no placebo).